A Randomized, Double-blind, Multi-center, Multi-factorial, Phase 2 Trial to Evaluate the Efficacy and Safety of S-Amlodipine/Telmisartan Combined or Alone and Select Better Dose of CKD-828 in Patients With Essential Hypertension.
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2011
At a glance
- Drugs Levamlodipine; Levamlodipine/telmisartan; Telmisartan
- Indications Essential hypertension
- Focus Therapeutic Use
- 25 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Nov 2010 Actual initiation date (Jul 2010) added as reported by ClinicalTrials.gov.
- 17 Nov 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.